VerifiedBiotechnology Research· Founded 2018

89bio

89bio was acquired by Roche in September 2025, making the company a member of the Roche Group. We look forward to advancing our innovative FGF21 analog, pegozafermin, as part of Roche’s Pharmaceuticals Division and continuing our mission to help patients with serious liver and cardiometabolic diseases. Pegozafermin is currently being evaluated in Phase 3 trials for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) and severe hypertriglyceridemia (SHTG).

7-day free trial · no credit card

San Francisco, United States149(11 to 50)$1M to <$10M201889bio.com LinkedIn

Verified contacts

106

available on Kipplo

LinkedIn employees

149

11 to 50 range

Open roles

3

across 1 depts

Distinct roles

58

indexed titles

Tech stack

2

tools in use

Monthly traffic

216

organic / mo

Hiring · 3 open positions across 1 departments

IT3

Sign up free to see all 106 verified contacts at 89bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

106 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 106 verified contacts

Top roles at 89bio

58 distinct titles indexed · top 10 shown.

4director, cmc operations
4senior clinical research associate
2, -
2clinical research associate
2director of cmc quality assurance
2director supply chain
2grade 8 teacher
1()
1(,)
1associate director clinical operations
+48more titles

Sign up to unlock all 106 contacts at 89bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 106 verified contacts at 89bio

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

89bio | Kipplo Discover